Acorah Software Products - Accounts Production 15.0.600 false true false true No description of principal activity 15 December 2022 31 December 2023 31 December 2023 14542920 Dr Andreas Shiatis Mrs Andrea Sherry iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14542920 2022-12-14 14542920 2023-12-31 14542920 2022-12-15 2023-12-31 14542920 frs-core:CurrentFinancialInstruments 2023-12-31 14542920 frs-bus:PrivateLimitedCompanyLtd 2022-12-15 2023-12-31 14542920 frs-bus:FilletedAccounts 2022-12-15 2023-12-31 14542920 frs-bus:Micro-entities 2022-12-15 2023-12-31 14542920 frs-bus:AuditExempt-NoAccountantsReport 2022-12-15 2023-12-31 14542920 frs-bus:Director1 2022-12-15 2023-12-31 14542920 frs-bus:CompanySecretary1 2022-12-15 2023-12-31
Registered number: 14542920
EUMORPHIA LTD
Unaudited Financial Statements
For the Period 15 December 2022 to 31 December 2023
Balance Sheet
Registered number: 14542920
31 December 2023
£
Current assets 24,200
Prepayments and accrued income 1,638
Creditors: Amounts Falling Due Within One Year (6,503 )
NET CURRENT ASSETS 19,335
TOTAL ASSETS LESS CURRENT LIABILITIES 19,335
Accruals and deferred income (900 )
NET ASSETS 18,435
CAPITAL AND RESERVES 18,435

Notes

1. General Information
EUMORPHIA LTD is a private company, limited by shares, incorporated in England & Wales, registered number 14542920 . The registered office is Office 431, Building 3 North London Business Park, Oakleigh Road South, London, N11 1GN.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
For the period ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Dr Andreas Shiatis
Director
12 September 2024